loader2
Partner With Us NRI

Company details

535.00
544.15
485.40
738.40
6M Return -18.11%
1Y Return -6.98%
Mkt Cap.(Cr) 306.18
Volume 491
Div Yield 1.66%
OI
-
OI Chg %
-
Volume 491

Open Free Demat Account Online with ICICIDIRECT

SWOT

  • swot

  • technicals

  • deals

  • shareholding


EMA SMA

Delivery and volume

Financials

  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio

Sales(Cr.)

Operating Profit(Cr.)

Profit after Tax(Cr.)

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after tax

PE

Debt/Equity

P BV

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 279.47 Cr FV: 10.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 2,805.20 26,355.35
LAST 3M 41,700.80 -10,395.59
LAST 6M 127,269.18 -151,588.49
LAST 12M 214,610.04 -219,403.16

Information

  • About Company
  • Company Info
  • Listing Info
11.64
61.99%
489.4464
17.16%
13.46%
Description
  • Incorporated in 1938 at Calcutta, Albert David (ADL) is headed by Chairman A K Kothari. Its units at Calcutta, Ghaziabad and Raisin manufacture pharmaceutical formulations, including amino acid infusions. The company also manufactures disposable syringes and needles and a wide range of bulk drugs. It is recognised as a large IV fluid manufacturer, both in glass and polyethylene containers. ADL has entered into a technical collaboration with Morishita Pharmaceuticals, Japan, a subsidiary of Ajinomoto -- the world leader in amino acids -- to manufacture amino acid infusions, for which it came out with a rights issue in Aug.`87. It has also set up a new unit in Kalyani, West Bengal, to manufacture bulk drugs, which went on stream in 1990. Another rights issue in Mar.`90 augmented the long-term working capital. ADL has entered into technical collaboration with Pharma Plan, Germany, to supply machinery to manufacture 30 mln disposable syringes and 70 mln needles at Mandideep near Bhopal. ADL came up with a Rs 4.68-cr right issue to part finance the expansion of its capacity of IV fluids in plastic bottles (FFS technology) at Ghaziabad. During 1998-99, the company has developed some new products viz. Siozole Capsules and Ferrochelate-Z-Capsules with Iron & Zinc and folic acid in sustained released formulation. In 2002-03 the company has launched new products-INTECAR,NIMERIL-T,EVICT,ALROF-50. It is also planning to launch new products such as SIOOXY,ALAMIN FEZ,PANSURE.

Read More

Registered Address

D Block 3rd Flr Gillander Hous, Netaji Subhas Road, Kolkata, West Bengal, 700001

Tel : 91-33-22302330/2262 8436/8456/
Email : adidavid:dataone.in
Website : http://www.albertdavidindia.com

Registrar

Maheshwari Datamatic Pvt Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 524075
NSE Code : ALBERTDAVD
Book Closure Date (Month) : Sep
BSE Group : B
ISIN : INE155C01010

ICICIdirect Albert David Ltd FAQ

You can buy Albert David Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Albert David Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Aug 11, 2022 04:01 PM the closing price of Albert David Ltd was ₹ 536.50.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Aug 11, 2022 04:01 PM, the market cap of Albert David Ltd stood at ₹ 306.18.
The latest PE ratio of Albert David Ltd as of Aug 11, 2022 04:01 PM is 11.64
The latest PB ratio of Albert David Ltd as of Aug 11, 2022 04:01 PM is 0.90
The 52-week high of Albert David Ltd is ₹ 738.40 while the 52-week low is ₹ 485.40 .

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote

CLOSE